GBS News and Press, GBS Inc. From 04/06/22

Gainers: Advent Technologies (ADN) +79%. Tufin Software Technologies (TUFN) +43%. Mobiquity Technologies (OTCQB:MOBQ) +30%. Missfresh (MF) +25%. Venator Materials (VNTR) +17%. Team (TISI) +16%. Concord Medical Services (CCM) +15%. NextDecade (NEXT) +15%. Smart Sand (SND) +13%. ...

Gainers: Sunshine Biopharma (SBFM) +132%. Dingdong Limited (DDL) +29%. System1 (SST) +27%. FG Financial Group (FGF) +25%. Missfresh (MF) +21%. BT Brands (BTBD) +20%. Longeveron (LGVN) +18%. Compass Therapeutics (CMPX) +18%. Allego (ALLG) +17%. Nam Tai Property (NTP) +15%. Losers: IMARA (IMRA)...

Gainers: Sunshine Biopharma (SBFM) +181%. Nano-X Imaging (NNOX) +15%. Arcus Biosciences (RCUS) +13%. Cue Biopharma (CUE) +11%. Dermata Therapeutics (DRMA) +6%. Losers: IMARA (IMRA) -35%. GBS (GBS) -15%. Precipio (PRPO) -13%. Cassava Sciences (SAVA) -10%...

Diagnostics company GBS (NASDAQ:GBS) on Thursday obtained institutional review board approval to start enrolling subjects in a trial designed to support the clinical development of the company's Saliva Glucose Biosensor. Shares rise about 5% in after market hours. The study will enroll about ...

The trial is single center, prospective study to collect coincident samples of oral fluid and blood to evaluate the time-course of glucose Trial is expected to enroll approximately 40 adult subjects diagnosed with type 2 diabetes GBS is seeking to support clinical valida...

Why Investors Are Watching These 4 Trending Penny Stocks If you’re looking to get in on the action with penny stocks, it’s important to know which stocks are trending and how to find them. Utilizing methods for finding trending penny stocks can help you to have a great...

The shares of biosensor diagnostic technology company GBS’s (GBS) have slumped more than 50% in price this year, reflecting investors’ pessimism. The company’s weak financial position seems to be overshadowing the company’s positive developments. So, will the penny...

NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- GBS (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that Dr. Steven Boyages, GBS’ interim CEO and Chair...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! It’s time to get into the thick of it with the biggest pre-market stock movers for Tuesday! Source: Eric Urquhart/Shutterstock.com Moving stocks this morning are reverse stock splits, ...

GBS Inc. (GBS) Q2 2022 Results Conference Call February 10, 2021 04:30 PM ET Company Participants Tim McCarthy - Investor Relations Steven Boyages - Chairman and Chief Executive Officer Spiro Sakiris - Chief Financial Officer Conference Call Participants John Vandermosten - Zacks Small Capita...